Genome Canada has announced the appointment of Dr. Rob Annan as the organization’s new President and CEO, starting January 1, 2020. 

In a news release, Chair of the Board of Genome Canada, Dr. Elizabeth Douville said “Dr. Annan’s leadership comes at an important time in the evolution of advanced biosciences. The pace of change is so astonishing – in gene-editing, synthetic biology, big data and artificial intelligence – that as an organization, we really have a responsibility to evolve. I am confident that Dr. Annan’s ability to transform his passion for research into purpose will be at the core of how we shape the next chapter of this cutting-edge science.” She added that Dr. Annan’s appointment follows a robust national and international executive search led by a special sub-committee of the Board.

Read the news release


View All Blogs